Comparison of baseline characteristics of patients who maintained aMCD and transformed to iMCD
| . | Patients who maintained aMCD . | Patients who transformed to iMCD . | P value . |
|---|---|---|---|
| Sex, male, n (%) | 55 (50.9%) | 5 (8.3%) | .122 |
| Age at diagnosis of aMCD, y | 43.2 ± 15.8 | 48.5 ± 21.3 | .436 |
| Involvement of both sides of the diaphragm, n (%) | 24 (22.2%) | 3 (50.0%) | .119 |
| HV subtype, n (%) | 53 (59.6%) | 2 (50.0%) | .704 |
| Receiving treatment for aMCD, n (%) | 40 (37.0%) | 3 (50.0%) | .524 |
| . | Patients who maintained aMCD . | Patients who transformed to iMCD . | P value . |
|---|---|---|---|
| Sex, male, n (%) | 55 (50.9%) | 5 (8.3%) | .122 |
| Age at diagnosis of aMCD, y | 43.2 ± 15.8 | 48.5 ± 21.3 | .436 |
| Involvement of both sides of the diaphragm, n (%) | 24 (22.2%) | 3 (50.0%) | .119 |
| HV subtype, n (%) | 53 (59.6%) | 2 (50.0%) | .704 |
| Receiving treatment for aMCD, n (%) | 40 (37.0%) | 3 (50.0%) | .524 |